Synaptogenix Inc (SNPX)

[SF Wolf]

That is not what happened "last time" when NTRP released the first P2 trial results PR. It was released with an incomplete data set, before the company did its own statistical analysis, and before they had the break-out trial results of the non-memantine AD patients.

Neurotrope will not make the same mistake twice.

As to the timing of the results, my expectation is the release will be in the fall of this year after the company has enough of the data to be absolutely sure of the claims they will make in Top Line PR.